Elanco Animal Health Inc - Understand $elan stock

$ELAN Market Cap: $6.056 Billion

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$4.454B

TTM

Gross Margin

54.46%

TTM

Net Earnings

$205.0M

TTM

Current Assets

$3.366B

Q3 2024

Current Liabilities

$1.321B

Q3 2024

Current Ratio

254.81%

Q3 2024

Total Assets

$13.28B

Q3 2024

Total Liabilities

$6.760B

Q3 2024

Book Value

$6.523B

Q3 2024

Cash

$490.0M

Q3 2024

P/E

29.54

Nov 29, 2024 EST

Free Cash Flow

$372.0M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$4.417B	$4.411B	$4.765B	$3.273B	$3.071B	$3.067B	$2.889B	$2.914B	$2.909B	$2.066B
YoY Change	0.14%	-7.43%	45.59%	6.58%	0.14%	6.15%	-0.84%	0.15%	40.81%	7.14%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$4.417B	$4.411B	$4.765B	$3.273B	$3.071B	$3.067B	$2.889B	$2.914B	$2.909B	$2.066B
Cost Of Revenue	$1.931B	$1.913B	$2.134B	$1.667B	$1.470B	$1.574B	$1.494B	$1.409B	$1.534B	$932.6M
Gross Profit	$2.486B	$2.498B	$2.631B	$1.606B	$1.601B	$1.493B	$1.395B	$1.505B	$1.375B	$1.133B
Gross Profit Margin	56.28%	56.63%	55.22%	49.07%	52.13%	48.68%	48.29%	51.64%	47.28%	54.86%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Selling, General & Admin	$1.285B	$1.265B	$1.404B	$996.0M	$760.0M	$735.2M	$779.8M	$784.8M	$916.0M	$561.2M
YoY Change	1.58%	-9.9%	40.96%	31.05%	3.37%	-5.72%	-0.64%	-14.32%	63.22%	9.82%
% of Gross Profit	51.69%	50.64%	53.36%	62.02%	47.47%	49.24%	55.9%	52.16%	66.6%	49.51%
Research & Development	$327.0M	$321.0M	$369.0M	$327.0M	$270.0M	$246.6M	$251.7M	$265.8M	$291.0M	$208.5M
YoY Change	1.87%	-13.01%	12.84%	21.11%	9.49%	-2.03%	-5.3%	-8.66%	39.57%	-3.65%
% of Gross Profit	13.15%	12.85%	14.03%	20.36%	16.86%	16.52%	18.04%	17.67%	21.16%	18.4%
Depreciation & Amortization	$694.0M	$682.0M	$716.0M	$517.0M	$314.0M	$296.0M	$318.4M	$254.4M	$236.9M	$57.60M
YoY Change	1.76%	-4.75%	38.49%	64.65%	6.08%	-7.04%	25.16%	7.39%	311.28%	17.55%
% of Gross Profit	27.92%	27.3%	27.21%	32.19%	19.61%	19.83%	22.82%	16.91%	17.22%	5.08%
Operating Expenses	$1.612B	$1.586B	$1.773B	$1.323B	$1.030B	$981.8M	$1.032B	$1.051B	$1.370B	$827.3M
YoY Change	1.64%	-10.55%	34.01%	28.45%	4.91%	-4.82%	-1.82%	-23.31%	65.6%	6.56%
Operating Profit	$874.0M	$912.0M	$858.0M	$283.0M	$571.0M	$511.2M	$363.6M	$453.9M	$5.400M	$306.1M
YoY Change	-4.17%	6.29%	203.18%	-50.44%	11.7%	40.59%	-19.89%	8305.56%	-98.24%	-1.23%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Interest Expense	$277.0M	$241.0M	$236.0M	$150.0M	$79.00M	$29.60M	$0.00	$0.00
YoY Change	14.94%	2.12%	57.33%	89.87%	166.89%
% of Operating Profit	31.69%	26.43%	27.51%	53.0%	13.84%	5.79%	0.0%	0.0%
Other Income/Expense, Net	-$75.00M	-$32.00M	-$5.000M	$178.0M	-$28.00M	-$41.30M	$100.0K	$2.800M	-$1.600M	-$1.400M
YoY Change	134.38%	540.0%	-102.81%	-735.71%	-32.2%	-41400.0%	-96.43%	-275.0%	14.29%	-26.32%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Pretax Income	-$1.195B	-$72.00M	-$567.0M	-$672.0M	$78.00M	$114.1M	-$232.6M	-$22.40M	-$259.5M	$265.9M
YoY Change	1559.72%	-87.3%	-15.63%	-961.54%	-31.64%	-149.05%	938.39%	-91.37%	-197.59%	-13.67%
Income Tax	$36.00M	$6.000M	-$95.00M	-$112.0M	$10.00M	$27.60M	$78.10M	$25.50M	-$48.70M	$101.0M
% Of Pretax Income					12.82%	24.19%				37.98%
Net Earnings	-$1.231B	-$78.00M	-$472.0M	-$560.0M	$68.00M	$86.50M	-$310.7M	-$47.90M	-$210.8M	$164.9M
YoY Change	1478.21%	-83.47%	-15.71%	-923.53%	-21.39%	-127.84%	548.64%	-77.28%	-227.84%	-13.66%
Net Earnings / Revenue	-27.87%	-1.77%	-9.91%	-17.11%	2.21%	2.82%	-10.75%	-1.64%	-7.25%	7.98%
Basic Earnings Per Share	-$2.50	-$0.16	-$0.97	-$1.27	$0.18	$0.28	-$1.06
Diluted Earnings Per Share	-$2.50	-$0.16	-$0.97	-$1.27	$0.18	$0.28	-$1.06	-$134.5K	-$591.8K	$462.9K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Short-Term Investments	$352.0M	$345.0M	$638.0M	$495.0M	$334.0M	$475.0M	$323.0M	$259.0M
YoY Change	2.03%	-45.92%	28.89%	48.2%	-29.68%	47.06%	24.71%
Cash & Equivalents	$352.0M	$345.0M	$638.0M	$495.0M	$334.0M	$475.0M	$323.0M	$259.0M
Short-Term Investments
Other Short-Term Assets	$310.0M	$394.0M	$237.0M	$267.0M	$98.00M	$317.0M	$136.0M	$182.0M
YoY Change	-21.32%	66.24%	-11.24%	172.45%	-69.09%	133.09%	-25.27%
Inventory	$1.735B	$1.538B	$1.373B	$1.578B	$1.051B	$1.004B	$1.062B	$876.0M
Prepaid Expenses
Receivables	$842.0M	$797.0M	$833.0M	$872.0M	$817.0M	$652.0M	$567.0M	$585.0M
Other Receivables	$168.0M	$205.0M	$195.0M	$205.0M	$73.00M	$57.00M	$35.00M	$46.00M
Total Short-Term Assets	$3.407B	$3.279B	$3.276B	$3.417B	$2.373B	$2.505B	$2.124B	$1.947B
YoY Change	3.9%	0.09%	-4.13%	43.99%	-5.27%	17.94%	9.09%
Property, Plant & Equipment	$1.166B	$1.140B	$1.222B	$1.503B	$1.040B	$922.0M	$920.0M	$742.0M
YoY Change	2.28%	-6.71%	-18.7%	44.52%	12.8%	0.22%	23.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$26.00M	$27.00M	$22.00M	$33.00M	$19.00M	$15.00M	$12.00M	$9.000M
YoY Change	-3.7%	22.73%	-33.33%	73.68%	26.67%	25.0%	33.33%
Other Assets	$175.0M	$210.0M	$204.0M	$127.0M	$81.00M	$103.0M	$242.0M	$204.0M
YoY Change	-16.67%	2.94%	60.63%	56.79%	-21.36%	-57.44%	18.63%
Total Long-Term Assets	$10.96B	$12.21B	$13.21B	$14.28B	$6.613B	$6.452B	$6.816B	$6.153B
YoY Change	-10.29%	-7.53%	-7.49%	115.88%	2.5%	-5.34%	10.78%
Total Assets	$14.36B	$15.49B	$16.48B	$17.69B	$8.986B	$8.957B	$8.940B	$8.100B
YoY Change
Accounts Payable	$270.0M	$390.0M	$418.0M	$501.0M	$223.0M	$205.0M	$204.0M	$228.0M
YoY Change	-30.77%	-6.7%	-16.57%	124.66%	8.78%	0.49%	-10.53%
Accrued Expenses	$189.0M	$177.0M	$219.0M	$181.0M	$123.0M	$99.00M	$89.00M	$83.00M
YoY Change	6.78%	-19.18%	20.99%	47.15%	24.24%	11.24%	7.23%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$38.00M	$388.0M	$294.0M	$555.0M	$25.00M	$29.00M
YoY Change	-90.21%	31.97%	-47.03%	2120.0%	-13.79%
Total Short-Term Liabilities	$1.241B	$1.702B	$1.643B	$2.076B	$819.0M	$971.0M	$643.0M	$619.0M
YoY Change	-27.09%	3.59%	-20.86%	153.48%	-15.65%	51.01%	3.88%
Long-Term Debt	$5.736B	$5.448B	$6.025B	$5.572B	$2.331B	$2.443B	$0.00	$0.00
YoY Change	5.29%	-9.58%	8.13%	139.04%	-4.58%
Other Long-Term Liabilities	$595.0M	$390.0M	$532.0M	$668.0M	$189.0M	$231.0M	$265.0M	$225.0M
YoY Change	52.56%	-26.69%	-20.36%	253.44%	-18.18%	-12.83%	17.78%
Total Long-Term Liabilities	$6.331B	$5.838B	$6.557B	$6.240B	$2.520B	$2.674B	$265.0M	$225.0M
YoY Change	8.44%	-10.97%	5.08%	147.62%	-5.76%	909.06%	17.78%
Total Liabilities	$8.139B	$8.202B	$8.945B	$9.217B	$3.439B	$3.759B	$1.160B	$1.072B
YoY Change	-0.77%	-8.31%	-2.95%	168.01%	-8.51%	224.05%	8.21%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016
Basic Shares Outstanding	492.3M shares	488.3M shares	487.2M shares	441.4M shares	369.0M shares	313.7M shares	293.3M shares	293.3M shares
Diluted Shares Outstanding	492.3M shares	488.3M shares	487.2M shares	441.4M shares	370.3M shares	313.7M shares	293.3M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $6.0558 Billion

About Elanco Animal Health Inc

Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. The company is headquartered in Greenfield, Indiana and currently employs 9,300 full-time employees. The company went IPO on 2018-09-20. The firm is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. The company offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.

Industry: Pharmaceutical Preparations Peers: Catalent, Inc. CORCEPT THERAPEUTICS INC Harmony Biosciences Holdings, Inc. Intra-Cellular Therapies, Inc. JOHNSON & JOHNSON Organon & Co. Royalty Pharma plc Viatris Inc Zoetis Inc.